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The relationship between total body fat 
and distribution of body fat mass and 
markers of insulin resistance in young 
women with normal weight — a pilot study
ABSTRACT
Introduction. Total body fat and body fat distribution 
are factors closely associated with development of 
insulin resistance, including subjects with normal body 
weight and BMI (body mass index).
Objectives. The objective of the study was to determine 
relation between insulin resistance index and selected 
parameters of body fat distribution in potentially 
healthy young females with body mass index below 
25 kg/m2.
Material and methods. Study group consisted of 36 
women with a BMI < 25 kg/m2, who underwent an-
thropometric measurements, i.e.: height, weight, waist 
circumference, hip circumference and blood pressure 
measurement. The segmental body composition was 
measured by of the use of the bioelectric impedance 
analysis (BIA). Moreover, oral glucose tolerance test 
(OGTT) was performed with blood collection in 0, 60 
and 120 minute of the test. The fasting samples were 
used for determination of concentrations of glucose, 
insulin, C-peptide, a total cholesterol, triglycerides, HDL 
and LDL cholesterol. The following insulin resistance 
indices were calculated: HOMA-IR, HOMA2-IR, HOMA2-
%B, HOMA2-%S and IRI/G.
Results. All the volunteers presented normal glucose 
tolerance in 120 minute of the OGTT test, as well as 
normal values of IRI/G index. Moreover, for such pa-
rameters as: total cholesterol, HDL and LDL cholesterol, 
triglycerides and CRP no values outside the reference 
range were found. C-peptide concentration was found 
to be significantly correlated with total body fat 
(r = 0.532; p = 0.001) and trunk fat mass (r = 0.471; 
p = 0.004).
Conclusions. In the young, non-obese women it seems 
to be justified to test concentration of glucose and 
C-peptide while assessing potential insulin resistance 
with simultaneous examination of the total and trunk 
body fat. (Clin Diabet 2016; 5, 2: 41–48)
Key words: insulin resistance, body fat weight, 
bioelectric impedance
Introduction
In the last several years there was a number of 
studies conducted to definee detailed criteria of car-
diovascular disease, diabetes and metabolic syndrome 
probability [1–3]. The problem of these diseases is 
visible in the developed and developing countries, 
where the largest increase in new cases of the disease 
is observed and directly related to increasing number 
of obese people. Excessive body weight caused by 
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increase in body fat — especially the abdomen one is 
the main cause of increasing tissue insulin resistance 
[4]. This relationship is also found in people with nor-
mal body weight and BMI (body mass index), which 
indicates that fat tissue distribution is a key factor in 
development of metabolic disorder [5–7], in increas-
ingly younger people [8]. Insulin resistance seems to 
be one of the factors related to reproduction disorders, 
including risk of spontaneous abortion [9, 10]. Tissue 
insulin resistance is found not only in overweight or 
obese women, or ones suffering from polycystic ovary 
syndrome [11], but also in potentially healthy women 
with normal BMI [10]. 
The golden standard for determination of insulin 
resistance is euglycemic clamp, which is technically 
difficult and very burdensome for the body. In clinical 
conditions it is rarely used due to difficult procedure 
and high costs. In practice, indirect methods for as-
sessment of insulin resistance are used the most often, 
which are either fasting glucose and insulin concentra-
tion or oral glucose tolerance test (OGTT). One of such 
indices is ratio of insulin to glucose concentration in 
fasting condition, i.e. IRI/G ratio. However, the most 
commonly HOMA-IR (Homeostasis Model Assessment 
of Insulin Resistance) index that is also calculated based 
on fasting concentration of insulin and glucose is used 
[4]. Moreover, one can use HOMA2-IR index and index 
of beta cell function b HOMA-%B (Homeostasis Model 
Assessment of b-cell Function) as well as insulin sensitiv-
ity index HOMA-%S (Homeostasis Model Assessment of 
Insulin Sensitivity) that can be calculated using gener-
ally available HOMA2 calculator. Additional parameter 
used for assessment of insulin resistance is C-peptide 
concentration and increasing number of researchers 
points to appropriateness of its determination espe-
cially in young people [12].
Testing body fat quantity and distribution has 
become such a clinically important parameter that the 
International Diabetes Federation (IDF), in their “Plati-
num Standard” of additional tests related to metabolic 
syndrome, recommends analysis of body composition 
and body fat distribution using Dual-energy X-ray 
absorptiometry (DEXA) or computer tomography/mag-
netic resonance imaging (CT/MRI) [13]. These methods, 
although very accurate, are not widely available andare 
related to high costs and expose patient to unnecessary 
radiation [14]. There are few others methods for the 
measurement of body composition and assessment of 
the amount of body fat, among which the most com-
monly used is bioelectrical impedance analysis (BIA). 
The body composition test using BIA method is safe 
and can be conducted virtually regardless of health, 
age or sex. The BIA is a simple and minimally invasive 
method with high repeatability. The methods involves 
flow of low-intensity electric current and assessment 
of resistance of individual tissues. From the clinical per-
spective, systematic control of body composition allows 
effective monitoring of physical activity, diet used or 
applied therapy [15–17]. Additional advantage of the 
BIA is a short time of analysis, as well as easy-to-use, 
usually portable equipment [15].
In Poland obesity is diagnosed already in one of five 
young people and the number is constantly increasing. 
This is mainly related to the change in lifestyle, high-
-calorie diet as well as social and economic develop-
ment. Due to the global problem, preventive actions 
are underway all over the world in order to reduce the 
development of obesity, particularly among young 
people. However, the literature contains little data on 
insulin resistance markers in the group age of young 
people with normal body weight that could be useful 
information in prevention of civilisation disease result-
ing from increase of body fat [18]. 
Objective
The objective of the study was to determine rela-
tion between insulin resistance index and selected 
parameters of body fat distribution using BIA in po-
tentially healthy young females of body mass index 
below 25 kg/m2. 
Material and methods
Characteristics of study group
The study group consisted of 36 young females, 
students of Wroclaw Medical University, aged 20 to 23 
y.o. with BMI < 25, which did not report current health 
problems, chronic medication use and addictions. Addi-
tionally, none of the volunteers reported family history 
of metabolic diseases. The volunteers were informed 
about the purpose and the aim of the study and gave 
their written consent. 
Physical examination
On the study day the volunteers came to the Teach-
ing Medical Diagnostics Laboratory of the Wroclaw 
Medical University fasted, in early morning hours, 
i.e. between 7:30 and 8:30 AM. After completing the 
questionnaire, a physical examination was conducted 
involving height, weight, waist circumference, hip cir-
cumference and blood pressure measurement. Height, 
waist and hips circumference were measured with an 
accuracy of 0.5 cm. Waist circumference was measured 
in the midway between lower abdomen quadrant 
and lower rib edge, while hips circumference at the 
greatest circumference of the thigh. Body weight was 
measured using medical scales without footwear and 
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outerwear. The blood pressure was measured twice us-
ing sphygmomanometer at rest; the statistical analysis 
was performed for averaged values. Moreover, for each 
person waste-hips ratio (WHR) and body mass index 
(BMI) were calculated.
Body composition analysis
Segmental body composition measurement was 
performed using the Tanita Model BC 418 MA analyser. 
The analyser, using 8 electrodes, allows precise estima-
tion of body fat and body muscle in individual body 
segments, particularly of fat tissue located inside the 
abdominal cavity. The following values were used in 
statistical analysis: total fat mass (FM), trunk fat mass 
(TFM), total body water (TBW), muscle mass (MM) and 
fat free mass (FFM) (Tab. 1).
Laboratory tests
From all volunteers, in fasting conditions, venous 
blood was collected with K3EDTA as an anticoagulant to 
obtain plasma and with coagulant activator in order to 
obtain serum. Then, among the volunteers, whose fast-
ing glucose concentration in plasma was < 126 mg/dl, 
oral glucose tolerance test was performed for 75 g of 
glucose. 
The fasting samples were used for determination 
of the concentrations of: glucose, insulin, C-peptide, 
total cholesterol, triglycerides, HDL and LDL cholesterol. 
In the samples collected in 60 and 120 minute of the 
OGTT, concentrations of glucose and insulin were 
determined. 
Glucose concentration in venous plasma was de-
termined using enzymatic colorimetric method GOD- 
-POD (Glucose GOD-POD, Thermo Fisher Scientific Inc., 
Vantaa, Finland); enzymatic colorimetric method was 
also applied for determination of triglycerides (Triglyc-
erides, Thermo Fisher Scientific Inc., Vantaa, Finland), 
total cholesterol (Thermo Fisher Scientific Inc., Vantaa, 
Finland) and HDL cholesterol (Thermo Fisher Scientific 
Inc., Vantaa, Finland), while LDL cholesterol was calcu-
lated using Friedewald equation. Insulin and C-peptide 
were determined using immunoenzymatic assay (DRG 
Insulin and C-Peptide ELISA Kit, DRG Instruments 
GmbH, Marburg, Germany). Metabolic characteristics 
of the study group is presented in Table 2.
For all the tests, appropriate control materials 
were used.
Insulin resistance indices
HOMA-IR index was calculated based on fasting 
concentrations of insulin and glucose using the formula: 
HOMA-IR = fasting glucose concentration [mmol/L]  
× fasting insulin concentration [µIU/mL]/22.5
The study used also indices, modified by Levy et 
al., i.e. HOMA2-IR and HOMA2-%B and HOMA2-%S 
which were calculated using HOMA2 calculator avail-
able at the website of the Oxford Centre for Diabetes, 
Endocrinology and Metabolism (https://www.dtu.ox.ac.
uk/homacalculator/). Moreover, fasting insulin [µIU/mL] 
and glucose [mg/dL] ratio was determined — IRI/G.
Statistical analysis
The statistical analysis was performed using 
software called Statistica 10 (StatSoft, Tulsa, USA). 
Distribution normality of the tested variables was 
verified by Shapiro-Wilk test and by using Levene’s 
variance homogeneity test. In order to determine re-
lation between analysed parameters, Pearson’s linear 
correlation coefficient was applied — for parameters 
with normal distribution, or Spearman’s ranks were 
applied — if variable distribution was not normal. For 
the verification procedures the assumed significance 
level was p < 0.05. 
Due to the fact that the majority of parameters did 
not have normal distribution, the results are presented as 
median and range between first and third quartile (Q1–Q3).
Table 1. Anthropometric characteristics and distribution 
of body mass of participants
Parameter Median Q1–Q3
Anthropometric data
Height [cm] 165.0 163.5–175.5
Body weight [kg] 54.6 51.9–61.2
Age (years) 22 21–23
Systolic blood pressure [mm Hg] 110 105–117
Diastolic blood pressure [mm Hg] 70 67–75
Waist circumference [cm] 72.0 69.0–78.5
Hip circumference [cm] 93.2 89.5–97.5
BMI [kg/m2] 20.2 19.3–21.9
WHR 0.78 0.76–0.82
Body composition parameters
Total fat mass [kg] 12.3 10.4–16.6
Total fat mass (%) 23.0 20.6–27.2
Total body water [kg] 31.2 29.6–33.5
Total body water (%) 56.4 53.2–58.2
Muscle mass [kg] 40.4 38.2–43.5
Muscle mass (%) 73.2 68.8–75.4
Fat-free mass [kg] 42.6 40.3–45.8
Fat-free mass (%) 76.9 72.5–79.4
Trunk fat mass [kg] 5.8 4.4–8.5
Trunk fat mass (%) 10.6 8.8–13.9 
BMI — body mass index, WHR — waist/hips ratio, Q1–Q3 — quartiles 1–3
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Results
Anthropometric characteristics and body mass dis-
tribution of tested volunteers are presented in Table 1. 
The total body fat mass for 25–75 percentile in the 
tested group was in the range of 10.4–16.6 [kg]. How-
ever, the relative body fat mass exceeding acceptable 
percentage for age and sex of > 30% was observed in 
3 women (8.3%) despite correct values of BMI (median: 
20.2 — with maximum: 24.6). Central obesity measured 
as waist circumference ≥ 80 cm was found in 22.2% 
women. All the parameters of body fat distribution 
(both absolute and relative values) were correlated 
with waist circumference significantly, while the most 
significant correlation coefficient was found for trunk 
fat mass (WC vs. TFM r = 0.657, p < 0.001).
Table 2 presents metabolic characteristics of the 
tested group and the most popular insulin resistance 
indices. Under the basic conditions, glucose and insu-
lin concentration were in range of reference values, 
while for glucose those were so-called high normal 
values (> 4.9 mmol/L). 21 women (58.3%) presented 
an increased fasting concentration of C-peptide (1.05 
nmol/L) whereas, over 3.31 nmol/L was found in three 
of them. In turn, for such parameters as: total choles-
terol, HDL and LDL cholesterol, triglycerides and CRP, 
no values outside the allowable concentration range 
were found. In all tested volunteers normal glucose 
tolerance in 120 minute of the OGTT [19] and normal 
values of IRI/G ration were observed. Interestingly, in 
the tested group, a relatively high median of HOMA-
-IR index was found, equal to 2.4. At the same time it 
was found that the studied group had normal function 
of pancreas beta cells (HOMA2-%B), with median of 
insulin sensitivity index HOMA2-%S being 72.1.
It is surprising that fasting glucose concentration 
had negative correlation with total fat mass (r = –0.404; 
p = 0.015), and also with absolute trunk fat mass (r = –0.417; 
p = 0.012). C-peptide, however, was significantly corre-
lated with total fat mass (r = 0.532; p = 0.001) and trunk 
fat mass (r = 0.471; p = 0.004) (Fig. 1). Moreover, relative 
value of FM was correlated with C-peptide (r = 0.362; 
p = 0.030) and similar significance was found for TFM 
percentage and HOMA2-%B (r = 0.356; p = 0.033). 
There was no correlation between insulin concentration 
in any point of OGTT, for both absolute and relative 
values, observed (Tab. 3). 
Discussion
The World Health Organisation (WHO) places great 
emphasis on prevention of civilisation diseases, which 
are the consequence of development of tissue insulin 
resistance, including diabetes, cardiovascular diseases 
and metabolic syndrome [1, 2]. Despite that, in data-
bases such as PubMed there is a rather small number 
of papers relating to young, potentially healthy people, 
for whom probability of insulin resistance was verified 
in correlation with selected parameters of fat tissue 
[20]. Moreover, in such health conditions as polycystic 
ovary syndrome, insulin resistance in slim women is 
observed in 30% of cases, while for obese women 
this value reaches up to 80%. Due to that, constant 
monitoring of fat mass and fat distribution in correla-
tion with tissue insulin resistance indices seems to be 
crucial for women of childbearing age [9].
The recognised factor of development of insulin 
resistance is increase in total fat mass, especially in 
the abdomen part [21, 22]. In the last several years it 
was shown that central obesity is a better predictor of 
development of insulin resistance that commonly used 
body mass index. It is recommended that evaluation of 
central obesity, expressed as waist circumference, shall 
be used in clinical practice for assessment of risk of de-
velopment of type 2 diabetes, even in people with BMI 
< 25 kg/m2 [23]. Waist circumference measurement 
Table 2. Metabolic characteristics of subjects 
Parameter Median Q1–Q3
Carbohydrate metabolism parameters
Fasting glucose [mmol/L] 5.1 4.9–5.4
Glucose 60’ [mmol/L] 5.3 4.6–6.4
Glucose 120’ [mmol/L] 5.1 4.4–5.9
Fasting insulin [µIU/mL] 10.8 9.2–14.0
                       [pmol/L] 65 55–84
Insulin 60’ [µIU/mL] 55.5 34.4–84.3
                 [pmol/L] 333 206–506
Insulin 120’ [µIU/mL] 44.3 28.5–67.6
[pmol/L] 266 171–406
C-peptide [nmol/L] 1.16 0.60–1.69
Indirect insulin resistance indices
IRI/G 0.1 0.1–0.2
HOMA-IR 2.4 2.1–3.2
HOMA2-IR 1.4 1.2–1.8
HOMA2-%B 124.5 102.6–137.4
HOMA2-%S 72.1 55.2–84.6
Lipid metabolism parameters
Total cholesterol [mmol/L] 4.30 3.78–4.87
HDL cholesterol [mmol/L] 1.53 1.42–1.71
LDL cholesterol [mmol/L] 2.49 1.94–2.74
Triglycerides [mmol/L] 0.70 0.60–1.17
C-reactive protein 0.7 0.2–1.7
CRP — C-reactive protein, HOMA-IR — Homeostasis Model Assessment 
of Insulin Resistance, HOMA2-IR — Homeostasis Model Assessment, ver-
sion 2, HOMA2-%B — Homeostasis Model Assessment of b-cell Function, 
HOMA2-%S — Homeostasis Model Assessment of Insulin Sensitivity,  
IRI/G — insulin/glucose ratio, Q1–Q3 — quartiles 1 and 3
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used for diagnosis of metabolic disease is continu-
ously assessed, and becomes more and more rigorous 
parameter determined separately for each population. 
Currently, for the European women according to the IDF 
criteria, this value is ≥ 80 cm [1, 13]. In the examined 
group of volunteers, WC median was 72 cm, while cen-
tral obesity measured according to waist circumference 
was found in 8 women (22.2%), whereas it must be 
noted that maximum WC was 89 cm. Despite the small 
group, the values are similar to the values obtained by 
Miazgowski et al. (26.2%), who studied a group of 145 
young women from Polish population [22]. 
Figure 1. Plots of value scatter for fasting glucose, insulin and C-peptide in correlation with total fat mass [kg] and trunk fat 
mass [kg]
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In medical practice, BMI is still used for expressing 
estimated fat mass, despite its limitations. Its main 
limitation is the lack of distinction between fat mass 
and muscle mass [23, 24] as well as the fact that it gives 
no information on body fat distribution [25]. Therefore, 
there is an increasing trend of recommending body 
composition measurements, especially using generally 
available techniques such as BIA. In our studies we have 
also observed a strong correlation between BMI and 
FM (r = 0.756; p < 0.001) and a negative correlation 
between BMI and MM (r = –0.764; p < 0.001). Accurate 
estimation of fat and muscle mass in individual body 
segments, particularly visceral adipose tissue located 
inside the abdominal cavity, allows precise determina-
tion of health risks related to development of tissue 
insulin resistance. 
In clinical practice, commonly used insulin resist-
ance indices involve simultaneous determination of 
glucose and insulin concentration, in basic conditions 
or during functional tests (mainly OGTT). The deter-
mined values can be used for calculation of so-called 
indirect insulin resistance indices. The simplest one 
is a ratio of fasting blood concentration of insulin 
[mIU/L] and glucose [mg/dL] — IRI/G. The decisive 
value suggesting insulin resistance is > 0.3 [26]. All 
the tested volunteers presented normal values of IRI/G 
ratio. Moreover, in the tested group there was no 
significant correlation found for IRI/G ratio with the 
total or trunk fat mass.
Another indirect insulin resistance index is a 
mathematical model HOMA-IR, evaluating relation 
between generation of glucose in the liver and func-
tion of pancreas beta cells that regulate concentration 
of glucose and insulin. HOMA-IR reflects mainly insulin 
sensitivity in fasted conditions and, to a limited extent, 
a possibility of determination of insulin resistance after 
meal [27]. Matthews et al. [28] presented a strong cor-
relation between HOMA-IR and insulin sensitivity index 
determined by means of hyperinsulinemic-euglycemic 
clamp, which is recognised as golden standard for as-
sessment of insulin resistance. Due to the complexity 
and invasiveness of the method and high costs of the 
procedure, the technique is not appropriate for epide-
miology studies, therefore routine diagnostics uses indi-
rect insulin resistance indices, including HOMA-IR [29]. 
The value of HOMA-IR for young people with normal 
body mass in ideal conditions should be 1.0. However, 
this index depends on many factors, including age, sex, 
ethnicity or fat mass, therefore it is difficult to estab-
lish cutoff of HOMA-IR, which have to be determined 
separately for each population [30]. Moreover, this 
parameter has certain clinical limitations, especially for 
people with impaired glucose tolerance [27]. For Polish 
population cutoff of HOMA-IR was determined among 
others by Szurkowska et al. They determined its value, 
for which insulin resistance can be diagnosed, as the 
upper quartile of distribution in population of normal 
glucose tolerance and normal body weight, i.e. HOMA-
-IR > 2.1 [31] while Żyła [30] has adopted value ≥ 2.5. 
By cutoff value of HOMA-IR ≥ 2.5, insulin resistance 
could be diagnosed in over 47% of tested volunteers. 
However, assuming that the study group consisted of 
Table 3. Correlations of total fat mass (FM) and trunk fat mass (TFM) with indicators of insulin resistance. Correlations 
of total fat mass (FM) and trunk fat mass (TFM) with indicators of insulin resistance
Parameter FM TFM
[kg] (%) [kg] (%)
r p r p r p r p
Fasting glucose –0.404 0.015 –0.236 0.166 –0.417 0.012 –0.322 0.055
Glucose 60’ –0.149 0.386 –0.184 0.282 –0.297 0.078 –0.262 0.123
Glucose 120’ –0.075 0.665 –0.127 0.459 –0.203 0.234 –0.193 0.260
Fasting insulin 0.105 0.543 0.187 0.275 0.052 0.764 0.187 0.276
Insulin 60’ –0.003 0.987 –0.027 0.874 –0.120 0.485 –0.085 0.622
Insulin 120’ –0.040 0.819 0.254 0.134 –0.136 0.431 0.267 0.116
IRI/G ratio 0.299 0.077 –0.048 0.780 0.270 0.111 –0.108 0.530
HOMA-IR 0.116 0.499 0.103 0.548 0.091 0.596 0.085 0.623
HOMA-%S –0.203 0.234 –0.169 0.325 –0.167 0.332 –0.156 0.364
HOMA-%B 0.396 0.017 0.327 0.052 0.363 0.029 0.356 0.033
HOMA2-IR 0.219 0.199 0.175 0.307 0.170 0.323 0.166 0.335
C-Peptide 0.532 0.001 0.362 0.030 0.471 0.004 0.314 0.062
Pearson’s linear correlation coefficients were used for parameters with normal distribution, while Spearman’s ranks were applied, if variable distribution 
was not normal
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potentially healthy people of normal body weight and 
adopting insulin resistance diagnosis cutoff based on 
HOMA-IR — upper quartile, the value would be ≥ 3.2. 
This is a value close to Q3 of the entire group tested 
by Szurkowska et al., which greatly shifts the cutoff 
value for insulin resistance diagnosis in our population. 
All the tested women had normal fat mass for their 
sex, age and ethnicity. The body fat mass increases with 
age. Age median of our volunteers was 10 years lower 
than for group tested by Miazgowski et al. [22], and 
despite comparable BMIs and fat-free mass (so-called 
lean mass), fat mass in our group is lower. This can be 
also a result of the equipment used in this study and 
its accuracy in comparison with reference method [15]. 
It seems interesting that trunk fat mass is corre-
lated negatively with fasting concentration of glucose 
(r = –0.417; p = 0.014). In volunteers participating 
in the study, normal fasting glucose concentrations 
were found, but those were high values (median 
5.1 mmol/l). However, there was no dependence found 
for fasting insulin nor any other insulin resistance 
indices in relation to trunk fat mass while correlation 
of C-peptide with the total body fat mass was found 
to be significantly positive (r = 0.532; p = 0.005). 
C-peptide is synthesised by pancreas beta cells in 
equimolar quantities in relation to insulin, but due to 
the longer half-life, C-peptide concentrations in fast-
ing conditions were five times higher than for insulin. 
C-peptide determination allows evaluation of current 
functional conditions of pancreas beta cells and is very 
useful parameter prior to development of overt insulin 
resistance [32]. Therefore, in potentially healthy people, 
from a diagnostic perspective, C-peptide seems a more 
adequate parameter than insulin for determination of 
function of pancreas beta cells. Moreover, Min et al. 
has found that C-peptide is a better predictor of risks 
of complications of cardiovascular and coronary artery 
disease than the glycated hemoglobin, or concentration 
of glucose in fasting conditions [12].
Our research, although conducted on a relatively 
small group of subjects, provides results justify its 
continuation on extended young people population, 
especially regarding the diagnostic importance of 
C-peptide as one of parameters of tissue insulin resist-
ance development. 
Conclusions
In young, non-obese women there is a significant 
correlation between total and trunk body fat and 
fasting C-peptide concentration. There was no such 
correlation for insulin and FM or TFM, in any of the 
three timepoints of the OGTT. Therefore, during the 
assessment of insulin resistance risk in young people, 
next to routinely performed glycemia assays, it seems 
justified to perform additional determination of 
C-peptide concentration and regular examination of 
total fat mass, with special emphasis on trunk fat mass. 
As it turns out, calculation of BMI may be definitely 
insufficient for determination of cardiometabolic risks 
in young women, as every fifth subject with normal 
BMI had abnormal waist circumference. And as the 
study shows, it is the trunk fat mass that is significantly 
correlated with C-peptide. At the time of diabetes epi-
demic, early diagnosis of disturbances in carbohydrate 
metabolism and determination of risk of development 
of insulin resistance in young, potentially healthy per-
sons is a crucial action for preventing development of 
civilisation diseases. 
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